Point72 Asset Management, L.P. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 65 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$4,129,000
+107.1%
1,100,994
+228.5%
0.02%
+100.0%
Q2 2022$1,994,000
-7.7%
335,108
-1.9%
0.01%
-11.1%
Q1 2022$2,161,000
+61.8%
341,6850.0%0.01%
+80.0%
Q4 2021$1,336,000
-19.0%
341,6850.0%0.01%
-28.6%
Q3 2021$1,650,000
+23.2%
341,685
+63.0%
0.01%
+16.7%
Q2 2021$1,339,000209,5630.01%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Western Standard LLC 869,354$2,895,0003.47%
22NW, LP 1,241,896$4,136,0002.24%
Newtyn Management, LLC 1,199,606$3,995,0001.46%
WITTENBERG INVESTMENT MANAGEMENT, INC. 186,198$620,0000.35%
Yakira Capital Management, Inc. 66,934$223,0000.10%
Sepio Capital, LP 210,534$701,0000.08%
Nantahala Capital Management 747,635$2,490,0000.08%
Watson Rebecca 3,068$10,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 61,700$205,0000.00%
WEBSTER BANK, N. A. 3,055$10,0000.00%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders